European Commission Directorate-General for International Partnerships (EuropeAid HQ)

LIACFLASH: a life changing IOeRT technology for oncology care: LIAC FLASH

Last update: Mar 28, 2023 Last update: Mar 28, 2023

Details

Locations:Italy
Start Date:Dec 1, 2022
End Date:Nov 30, 2024
Contract value:EUR 3,571,375
Sectors:Health, Science & InnovationHealth, Science & Innovation
Categories:Grants
Date posted:Mar 28, 2023

Associated funding

Associated experts

Description

Programme(s): HORIZON.3.1 - The European Innovation Council (EIC)

Topic(s): HORIZON-EIC-2022-ACCELERATOROPEN-01 - EIC Accelerator Open

Call for proposal: HORIZON-EIC-2022-ACCELERATOR-01

Funding Scheme: EIC-ACC - EIC-ACC

Grant agreement ID: 190151856

Objective:
Radiation Therapy is, along with surgery, the most effective therapeutic approach for the treatment of solid tumours. Unfortunately, biological effects of radiation dose to healthy organs at risk (often surrounding targeted tumour mass) represent a major dose-limiting constraint in Radiation Therapy. This implies that tumours cannot be always successfully treated, as delivered dose might not be enough for an effective treatment, decreasing survival of these cancer patients. LIACFLASH is an IOeRT system for cancer treatment built on a breakthrough scientific discovery: the FLASH effect, which enables delivery of high radiation dose with significantly reduced associated radiocytotoxicity, while achieving efficient tumour killing, widening the therapeutic window.

 

Want to unlock full information?
Member-only information. Become a member to access projects awards, find the right consortia partners, subcontractors and more.